Antengene - Insights on Pipeline and Valuation
This article analyzed the value and potential of Antengene's current pipeline, its competitors' products and also include some thoughts on valuation.
439 Views
Antengene IPO: Valuation Insights
Antengene has launched an HK IPO to raise net proceeds of $318 million at the mid-point of the price range. Overall, strong cornerstones and our...
495 Views
Antengene: We Like the Deal
This Insight recommends participating in the IPO of Antengene considering the proposed valuation and market opportunity.
423 Views
Antengene (德琪医药) IPO: Buy the Team
The deal has attracted a strong line-up of cornerstone investors. At the high end it is fairly valued but the sentiment appears to be strong again...
631 Views
ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
570 Views